Home > Balance Sheet > BIOCON

BIOCON
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹100 Cr₹74 Cr₹81 Cr₹-241 Cr₹-275 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?

The latest Deferred Tax Assets / Liabilities ratio of BIOCON is ₹100 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹100 Cr
Mar2024₹74 Cr
Mar2023₹81 Cr
Mar2022₹-241 Cr
Mar2021₹-275 Cr

How is Deferred Tax Assets / Liabilities of BIOCON Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹100 Cr
34.77
Mar2024 ₹74 Cr
-8.17
Mar2023 ₹81 Cr
Positive
Mar2022 ₹-241 Cr
Negative
Mar2021 ₹-275 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹57,168.3 Cr 0.3% -2.9% 4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3.5% -5.4% -3.2% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.6% 0.2% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -0.5% 5.9% 20.3% Stock Analytics
CIPLA ₹115,883.0 Cr -1.8% -4.8% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -1.7% -7.3% -12.1% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

0.3%

-2.9%

4.6%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses